Optilite Rheumatoid Factor Kit— 510(k) K162263
Substantially EquivalentThe Binding Site Group , Ltd.
FDA 510(k) clearance K162263 for Optilite Rheumatoid Factor Kit, Substantially Equivalent on 2017-05-03. Applicant: The Binding Site Group , Ltd.. Device class: 2.
Clearance details
- Applicant
- The Binding Site Group , Ltd.
- Product code
- Code DHR
- Device class
- Class 2
- Regulation
- 21 CFR 866.5775
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Birmingham, GB
Recent devices under product code DHR
view all- K192727 — K-ASSAY (R) RF (Ver.2), K-ASSAY (R) RF Calibrator (Ver.2)
- K190088 — QUANTA Flash RF IgM Reagents, QUANTA Flash RF IgA Reagents
- K182747 — EliA RF IgM Immunoassay
- K160070 — Rheumatoid Factor (RF) Kit for use on SPAPLUS
- K143736 — ImmuLisa Enhanced RF IgA Antibody ELISA, ImmuLisa Enhanced RF IgG Antibody ELISA, ImmuLisa Enhanced RF IgM Antibody ELISA, ImmuLisa Enhanced RF Antibody Screen ELISA
More clearances from The Binding Site Group , Ltd.
view allRecalls naming K162263
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K162263.
Data sourced from openFDA. This site is unofficial and independent of the FDA.